Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Wet Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03944070
What this trial is testing

Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

Who this might be right for
Wet Macular DegenerationCataract Extraction
Ophthalmica Eye Institute 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Post-approval studies (Phase 4)Study completedNCT02944227
What this trial is testing

Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
Seoul National University Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06707753
What this trial is testing

Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 21
Not applicableStudy completedNCT01318941
What this trial is testing

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Who this might be right for
Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionWet Age Related Macular DegenerationDiabetic Macular Edema+1 more
Novartis Pharmaceuticals 30,490
Not applicableUnknownNCT04268836
What this trial is testing

Vision Improvement for Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Optimal Acuity Corporation 200
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Not applicableLooking for participantsNCT04697095
What this trial is testing

Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants

Who this might be right for
Age Related Macular Degeneration
Hospices Civils de Lyon 80
Large-scale testing (Phase 3)Study completedNCT03034772
What this trial is testing

Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
Wills Eye 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557121
What this trial is testing

Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
AiViva BioPharma, Inc. 35
Early research (Phase 1)Ended earlyNCT00102115
What this trial is testing

Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Light Sciences LLC 27
Not applicableStudy completedNCT05082415
What this trial is testing

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,456
Early research (Phase 1)Looking for participantsNCT06132035
What this trial is testing

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Who this might be right for
Age-related Wet Macular Degeneration
Caregen Co. Ltd. 45
Testing effectiveness (Phase 2)Study completedNCT04626128
What this trial is testing

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 27
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Early research (Phase 1)Study completedNCT01691261
What this trial is testing

Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 9
Post-approval studies (Phase 4)Study completedNCT01986907
What this trial is testing

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Who this might be right for
Wet Age Related Macular Degeneration
Novartis Pharmaceuticals 1,049
Testing effectiveness (Phase 2)Ended earlyNCT02228304
What this trial is testing

Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Neurotech Pharmaceuticals 42
Not applicableStudy completedNCT05110209
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 331,541
Testing effectiveness (Phase 2)UnknownNCT01521065
What this trial is testing

An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationWet Macular DegenerationMacular Degeneration+2 more
Oraya Therapeutics, Inc. 500
Next Page